Pilot trial (bladder pain): In 2024, a private clinic published a pilot study treating 12 women with severe interstitial cystitis (bladder pain syndrome) by injecting 10 mg of BPC-157 into the bladder wall (urotoday.com)
At these concentrations, the GLP-1 receptor activation is sufficient to engage anti-inflammatory pathways without triggering the gastrointestinal side effects that make full-dose therapy difficult for many patients
The good news is that increasing your glutathione levels may reduce your headaches and chronic migraine attacks
Common side effects can include nausea, headaches, constipation, diarrhea, fatigue, and stomach pain
By being proactive and communicating openly with your medical team, you can navigate your health journey confidently.
For instance, in the STEP 4 trial, participants who discontinued Wegovy after 20 weeks regained approximately 70% of the weight they had lost within 48 weeks